Life expectancy for Progressive Supranuclear Palsy (PSP)

Life expectancy for Progressive Supranuclear Palsy (PSP)

The life expectancy for Progressive Supranuclear Palsy (PSP) varies widely depending on the individual and the progression of the disease. PSP is a rare neurodegenerative disorder that affects movement, balance, vision, speech, and cognitive function. While it is a progressive disease with no cure, the course of the disease can vary significantly from person to person.

On average, individuals with PSP live approximately 6 to 10 years after the onset of symptoms. However, some individuals may live much longer, while others may have a shorter life expectancy. Factors such as age at onset, rate of disease progression, and overall health can all play a role in determining life expectancy.

It's important to note that while there is no cure for PSP, there are treatments available that can help manage symptoms and improve quality of life. A healthcare team can work with individuals with PSP and their families to develop a care plan that addresses their specific needs and goals.

 

Check out our post on some treatments for PSP Symptoms:

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

  • Recruiting participants for a groundbreaking study: “Assessing Cognitive Trajectories in Progressive Supranuclear Palsy Using Remote Computerized Reaction Time Tasks.”

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

  • WAITING By Bhavna

    WAITING By Bhavna

    For four years, she had lived with the unraveling of a rare brain disease. Progressive Supranuclear Palsy. Each step making her more dependent. Each fall more brutal. And each word...

    2 comments

    WAITING By Bhavna

    For four years, she had lived with the unraveling of a rare brain disease. Progressive Supranuclear Palsy. Each step making her more dependent. Each fall more brutal. And each word...

    2 comments
1 of 4